NO20055990L - Anvendelse av et polypeptid - Google Patents

Anvendelse av et polypeptid

Info

Publication number
NO20055990L
NO20055990L NO20055990A NO20055990A NO20055990L NO 20055990 L NO20055990 L NO 20055990L NO 20055990 A NO20055990 A NO 20055990A NO 20055990 A NO20055990 A NO 20055990A NO 20055990 L NO20055990 L NO 20055990L
Authority
NO
Norway
Prior art keywords
polypeptide
biotinylated
modulate
enzyme
derivative
Prior art date
Application number
NO20055990A
Other languages
English (en)
Norwegian (no)
Inventor
Norbert Tennagels
Aimo Kannt
Harald Thuering
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of NO20055990L publication Critical patent/NO20055990L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO20055990A 2003-05-22 2005-12-16 Anvendelse av et polypeptid NO20055990L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10323081A DE10323081A1 (de) 2003-05-22 2003-05-22 Verwendung eines Polypeptides
PCT/EP2004/004428 WO2004104220A2 (de) 2003-05-22 2004-04-27 Verwendung eines biotinylierten polypeptides zur bestimmung der aktivität von protein-phosphorylierenden enzymen

Publications (1)

Publication Number Publication Date
NO20055990L true NO20055990L (no) 2006-02-14

Family

ID=33441119

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055990A NO20055990L (no) 2003-05-22 2005-12-16 Anvendelse av et polypeptid

Country Status (15)

Country Link
US (1) US7732151B2 (de)
EP (1) EP1627073A2 (de)
JP (1) JP4740858B2 (de)
KR (1) KR20060015290A (de)
CN (1) CN100560732C (de)
AU (1) AU2004241327B2 (de)
BR (1) BRPI0410783A (de)
CA (1) CA2526697A1 (de)
DE (1) DE10323081A1 (de)
HK (1) HK1092840A1 (de)
IL (1) IL172008A (de)
MX (1) MXPA05012521A (de)
NO (1) NO20055990L (de)
RU (1) RU2395813C2 (de)
WO (1) WO2004104220A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015155738A2 (en) 2014-04-09 2015-10-15 Christopher Rudd Use of gsk-3 inhibitors or activators which modulate pd-1 or t-bet expression to modulate t cell immunity
CN113933463B (zh) * 2021-10-14 2024-04-02 丽江英煌集生物工程有限公司 一种玛咖多肽活性的快速分检装置及分检方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0711341A4 (de) * 1993-07-29 2001-12-19 Cor Therapeutics Inc Rezeptorfunktionstests
US5763198A (en) * 1994-07-22 1998-06-09 Sugen, Inc. Screening assays for compounds
EP0873142A4 (de) * 1995-06-07 2001-08-08 Sugen Inc Überprüfungsteste für verbindungen
US5759787A (en) * 1996-08-26 1998-06-02 Tularik Inc. Kinase assay
AU6026698A (en) * 1997-01-15 1998-08-07 Telik, Inc. Modulators of insulin receptor activity
ES2192801T3 (es) * 1997-12-05 2003-10-16 Upjohn Co Ensayos de criba de alta productividad de proteina quinasas y fosfatasas, basados en fluorescencia.
AU5604900A (en) * 1999-06-09 2000-12-28 Ljl Biosystems, Inc. Phosphorylation assays

Also Published As

Publication number Publication date
KR20060015290A (ko) 2006-02-16
IL172008A (en) 2011-12-29
JP2007512802A (ja) 2007-05-24
HK1092840A1 (en) 2007-02-16
RU2005140091A (ru) 2006-05-10
DE10323081A1 (de) 2004-12-16
AU2004241327A1 (en) 2004-12-02
RU2395813C2 (ru) 2010-07-27
MXPA05012521A (es) 2006-05-25
US20080020399A1 (en) 2008-01-24
JP4740858B2 (ja) 2011-08-03
EP1627073A2 (de) 2006-02-22
US7732151B2 (en) 2010-06-08
WO2004104220A2 (de) 2004-12-02
AU2004241327B2 (en) 2010-03-25
BRPI0410783A (pt) 2006-06-20
WO2004104220A3 (de) 2005-06-09
CN100560732C (zh) 2009-11-18
CN1795273A (zh) 2006-06-28
CA2526697A1 (en) 2004-12-02

Similar Documents

Publication Publication Date Title
NO20052928L (no) Nye kjemiske forbindelser
NO20015096L (no) Måling og bruk av molekul¶re interaksjoner
DE60039616D1 (de) INHIBITOREN DER c-JUN N-TERMINALEN KINASE (JNK) UND ANDERE PROTEIN-KINASEN
DK2146024T3 (da) Gulvplader med tætningsmidler
TW200621253A (en) 2-amido-thiazole-based compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof
NO20045429L (no) Kombinasjon av organiske forbindelser
NO20052469D0 (no) Inhibitorer av II-beta-hydroksysteroid-dehydrogenase type 1 og type 2.
NO20040211L (no) Kombinasjon av en aldosteronreseptor for antagonist og en HMB COA-reduktaseinhibitor
WO2005017097A3 (en) Quorum sensing and biofilm formation
NO20065560L (no) Anvendelse av IL-17-uttrykking for a forutsi hudinflammasjon, fremgangsmater for behandling.
DE60136546D1 (de) Methode zum bekämpfen der allergien durch verwendung von substituierten pyrazolen
NO20070908L (no) Sammensmeltede ringheterocykelkinasemodulatorer
NO20044051L (no) Analyse for ACTRIIB-kinase aktivitet
DK1791958T3 (da) Gær/bakterie-to-hybridsystem og fremgangsmåder til brug deraf
DK1668001T3 (da) Substituerede heteroarylbenzofuransyrer
NO20034484D0 (no) Styring og/eller utpröving av hydrokarbonproduksjonssystem
ATE322361T1 (de) Isothiazolone/amine oxide holzschutzmittel
SG153662A1 (en) Bias sensing in dram sense amplifiers
NZ536103A (en) Peptide deformylase inhibitors
ATE484749T1 (de) Von anti-trichinella-antikörpern erkannte polypeptide und ihre verwendung
NO20055990L (no) Anvendelse av et polypeptid
NZ601647A (en) Variant hhip1 protein and methods and uses thereof
DE502004009217D1 (de) Differenzialdiagnostik mit Hepcidin
ATE543906T1 (de) Antigen von streptococcus aus der b-gruppe
DE60331059D1 (de) Verbesserter rezeptornachweis